High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins.

Abstract excerpt

Intermediate filament (IF) proteins have unique and complex cell and tissue distribution. Importantly, IF gene mutations cause or predispose to more than 80 human tissue-specific diseases (IF-pathies), with the most severe disease phenotypes being due to mutations at conserved residues that result in a disrupted IF network. A critical need for the entire IF-pathy field is the identification of drugs that can...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Evaluation, Preclinical
• Share to Intermediate Filament Proteins